Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Identification of Key Genes and Immunological Features Associated with Copper Metabolism in Parkinson’s Disease by Bioinformatics Analysis

    To explore diagnostic genes associated with cuproptosis in Parkinson’s disease (PD) and to characterize immune cell infiltration by comprehensive bioinformatics analysis, three PD datasets were downloaded from...

    Haofuzi Zhang, Jun Nagai, Lu Hao, **aofan Jiang in Molecular Neurobiology (2024)

  2. Article

    Open Access

    Neuronal DSCAM regulates the peri-synaptic localization of GLAST in Bergmann glia for functional synapse formation

    In the central nervous system, astrocytes enable appropriate synapse function through glutamate clearance from the synaptic cleft; however, it remains unclear how astrocytic glutamate transporters function at ...

    Ken-ichi Dewa, Nariko Arimura, Wataru Kakegawa, Masayuki Itoh in Nature Communications (2024)

  3. Article

    New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination

    Evans syndrome presents as concurrent autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Systemic lupus erythematosus (SLE) is the most frequent autoimmune disorder associated with Evans syn...

    Daisuke Hidaka, Reiki Ogasawara, Shunsuke Sugimura in International Journal of Hematology (2022)

  4. No Access

    Article

    Improved tools to study astrocytes

    Astrocytes are a type of glial cell that tile the CNS. They interact with multiple cell types, including neurons, glial cells and blood vessels, and are involved or implicated in brain disorders. Progress has ...

    **nzhu Yu, Jun Nagai, Baljit S. Khakh in Nature Reviews Neuroscience (2020)

  5. Article

    Open Access

    Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis

    Lysophosphatidic acid (LPA), generated by autotaxin (ATX), is a bioactive lipid mediator that binds to the receptors (LPA1–6), and serves as an important mediator in inflammation. Previous studies have demonstrat...

    Chie Miyabe, Yoshishige Miyabe, Jun Nagai, Noriko N. Miura in Arthritis Research & Therapy (2019)

  6. Article

    Open Access

    Genetic inhibition of CRMP2 phosphorylation at serine 522 promotes axonal regeneration after optic nerve injury

    Axonal degeneration occurs in various neurological diseases and traumatic nerve injury, and axonal regeneration is restricted by inhibitory factors in the central nervous system. Cyclin-dependent kinase 5 and ...

    Shunsuke Kondo, Kazuya Takahashi, Yuki Kinoshita, Jun Nagai in Scientific Reports (2019)

  7. Article

    Open Access

    A genetically encoded single-wavelength sensor for imaging cytosolic and cell surface ATP

    Adenosine 5′ triphosphate (ATP) is a universal intracellular energy source and an evolutionarily ancient, ubiquitous extracellular signal in diverse species. Here, we report the generation and characterization...

    Mark A. Lobas, Rongkun Tao, Jun Nagai, Mira T. Kronschläger in Nature Communications (2019)

  8. No Access

    Article

    CRMPs Function in Neurons and Glial Cells: Potential Therapeutic Targets for Neurodegenerative Diseases and CNS Injury

    Neurodegeneration in the adult mammalian central nervous system (CNS) is fundamentally accelerated by its intrinsic neuronal mechanisms, including its poor regenerative capacity and potent extrinsic inhibitory...

    Jun Nagai, Rina Baba, Toshio Ohshima in Molecular Neurobiology (2017)

  9. Article

    Open Access

    Lys39-Lysophosphatidate Carbonyl Oxygen Interaction Locks LPA1 N-terminal Cap to the Orthosteric Site and partners Arg124 During Receptor Activation

    Lysophosphatidic acid (LPA) receptor 1 (LPA1) is a member of the G protein-coupled receptors mediating the biological response to LPA species. Lack of detailed mechanism underlying LPA/LPA1 interaction has hamper...

    Olaposi I. Omotuyi, Jun Nagai, Hiroshi Ueda in Scientific Reports (2015)

  10. Article

    Open Access

    Crmp4 deletion promotes recovery from spinal cord injury by neuroprotection and limited scar formation

    Axonal outgrowth inhibitors and scar formation are two major obstacles to central nervous system (CNS) repair. No target molecule that regulates both axonal growth and scarring has been identified. Here we ide...

    Jun Nagai, Yoshiteru Kitamura, Kazuki Owada, Naoya Yamashita in Scientific Reports (2015)

  11. Article

    Open Access

    Lysophosphatidic acid and its receptors LPA1 and LPA3 mediate paclitaxel-induced neuropathic pain in mice

    Paclitaxel, which is widely used for the treatment of solid tumors, causes neuropathic pain via poorly understood mechanisms. Previously, we have demonstrated that lysophosphatidic acid (LPA) and its receptors...

    Hitoshi Uchida, Jun Nagai, Hiroshi Ueda in Molecular Pain (2014)

  12. No Access

    Article

    Antimicrobial prophylaxis to prevent perioperative infection in urological surgery: a multicenter study

    We prospectively investigated the rates of incidence of surgical site infection (SSI), urinary tract infection (UTI), and remote infection (RI) in 4,677 patients who underwent urological surgery from January t...

    Yoshikazu Togo, Shiro Tanaka, Akihiro Kanematsu in Journal of Infection and Chemotherapy (2013)

  13. No Access

    Article

    Interleukin-1β Plays Key Roles in LPA-Induced Amplification of LPA Production in Neuropathic Pain Model

    Lysophosphatidic acid (LPA) is a bioactive lipid mediator that exerts a wide range of biological actions. In recent decades, LPA has been demonstrated as an important initiator of neuropathic pain based on the...

    Ryo Yano, Lin Ma, Jun Nagai, Hiroshi Ueda in Cellular and Molecular Neurobiology (2013)

  14. Article

    Open Access

    An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model

    We previously reported that nerve injury-induced neuropathic pain is initiated by newly produced lysophosphatidic acid (LPA).

    Lin Ma, Jun Nagai, Jerold Chun, Hiroshi Ueda in Molecular Pain (2013)

  15. Article

    Open Access

    Pilocarpine suppresses hyperalgesia induced by intermittent cold stress (ICS) as an experimental fibromyalgia model in mice

    Jun Nagai, Michiko Nishiyori, Hiroshi Ueda in Arthritis Research & Therapy (2012)

  16. Article

    Open Access

    Permanent relief from intermittent cold stress-induced fibromyalgia-like abnormal pain by repeated intrathecal administration of antidepressants

    Fibromyalgia (FM) is characterized by chronic widespread pain, which is often refractory to conventional painkillers. Numerous clinical studies have demonstrated that antidepressants are effective in treating ...

    Michiko Nishiyori, Hitoshi Uchida, Jun Nagai, Kohei Araki, Takehiro Mukae in Molecular Pain (2011)

  17. Article

    Open Access

    Antinociceptive effect of cyclic phosphatidic acid and its derivative on animal models of acute and chronic pain

    Cyclic phosphatidic acid (cPA) is a structural analog of lysophosphatidic acid (LPA), but possesses different biological functions, such as the inhibition of autotaxin (ATX), an LPA-synthesizing enzyme. As LPA...

    Yasutaka Kakiuchi, Jun Nagai, Mari Gotoh, Harumi Hotta, Hiromu Murofushi in Molecular Pain (2011)

  18. Article

    Open Access

    Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine

    Although neuropathic pain is frequently observed in demyelinating diseases such as Guillain-Barré syndrome and multiple sclerosis, the molecular basis for the relationship between demyelination and neuropathic...

    Jun Nagai, Hitoshi Uchida, Yosuke Matsushita, Ryo yano, Mutsumi Ueda in Molecular Pain (2010)

  19. Article

    Open Access

    Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain

    We previously reported that intrathecal injection of lysophosphatidylcholine (LPC) induced neuropathic pain through activation of the lysophosphatidic acid (LPA)-1 receptor, possibly via conversion to LPA by a...

    Lin Ma, Hitoshi Uchida, Jun Nagai, Makoto Inoue, Jerold Chun, Junken Aoki in Molecular Pain (2009)

  20. No Access

    Article

    Intermittent short-term graded running performance in middle-distance runners in hypobaric hypoxia

    This study investigated whether in trained middle-distance runners, intermittent short-term graded running performance is affected by a hypobaric hypoxic environment (simulated 2,500 m) (H). Seven male middle-...

    Takeshi Ogawa, Keiichi Ohba, Yoshiharu Nabekura in European Journal of Applied Physiology (2005)

previous disabled Page of 2